Kala BIO, Inc.: which funds bought and sold
Institutions that bought and sold Kala BIO shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 13 institutions that filed 13F reports for both quarters added to or opened positions in Kala BIO, and 0 cut or closed them. Together they added a net 613K shares, — on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 11K shares; index fund managers were net buyers of 580K shares. 13 opened a new position and 0 sold out entirely.
Bought, Q2 2026 13 institutions, 13 of them new holders Sold, Q2 2026 0 institutions, 0 of them sold out
Net change, all compared +613K shares (—)
Net change, active managers +11K shares (—), 1 bought, 0 sold
Buyers versus sellers
13 bought 0 sold
Active managers and hedge funds 1 bought · 0 sold · +11K
Index fund managers 5 bought · 0 sold · +580K
Other institutions 7 bought · 0 sold · +21K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Vanguard Capital Management LLC Index funds | +221K New position | 221K | $381,678 |
| Geode Capital Management, LLC Index funds | +145K New position | 145K | $251,112 |
| Vanguard Fiduciary Trust Co Index funds | +101K New position | 101K | $175,415 |
| Blackrock, Inc. Index funds | +72K New position | 72K | $123,768 |
| Northern Trust Corp Index funds | +42K New position | 42K | $71,978 |
| Qube Research & Technologies Ltd Hedge fund | +11K New position | 11K | $19,156 |
| Goldman Sachs Group Inc | +11K New position | 11K | $18,893 |
| UBS Group AG | +9,057 New position | 9,057 | $15,669 |
| Tower Research Capital LLC (TRC) | +616 New position | 616 | $1,066 |
| Barclays PLC | +608 New position | 608 | $1,052 |
| Morgan Stanley | +28 New position | 28 | $48 |
| Caitong International Asset Management Co., Ltd | +10 New position | 10 | $17 |
| International Assets Investment Management, LLC | +2 New position | 2 | $4 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Qube Research & Technologies Ltd Hedge fund | +11K New position | 11K | $19,156 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| No institution cut its holding. | |||
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| None of the active managers on our list. | |||
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Vanguard Capital Management LLCIndex funds | 221K | $381,678 |
| Geode Capital Management, LLCIndex funds | 145K | $251,112 |
| Vanguard Fiduciary Trust CoIndex funds | 101K | $175,415 |
| Blackrock, Inc.Index funds | 72K | $123,768 |
| Northern Trust CorpIndex funds | 42K | $71,978 |
| Qube Research & Technologies LtdHedge fund | 11K | $19,156 |
| Goldman Sachs Group Inc | 11K | $18,893 |
| UBS Group AG | 9,057 | $15,669 |
| Tower Research Capital LLC (TRC) | 616 | $1,066 |
| Barclays PLC | 608 | $1,052 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| No institution sold its whole holding. | ||
Who holds the shares
- Institutions reporting
- 13
- Ten largest holders
- 100.0% of 13F-reported shares
- Index fund managers
- 94.7% of 13F-reported shares
- Active managers and hedge funds
- 1.8% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 1 | 0 | 1 | 0 | +11K | — |
| Index fund managers | 5 | 0 | 5 | 0 | +580K | — |
| Other institutions | 7 | 0 | 7 | 0 | +21K | — |